REG - Transense Technlgy - Final Results
Tue 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250923:nRSW3341Aa&default-theme=true
RNS Number : 3341A Transense Technologies PLC 23 September 2025
The information communicated within this announcement is deemed to constitute
inside information as stipulated under the Market Abuse Regulations (EU) No.
596/2014 which is part of UK law by virtue of the European Union (withdrawal)
Act 2018. Upon the publication of this announcement, this inside information
is now considered to be in the public domain.
23 September 2025
Transense Technologies plc
("Transense" or the "Company")
Final results for the year ended 30 June 2025
& notice of investor presentation
Transense Technologies plc (AIM: TRT), the provider of specialist sensor
systems, announces its final results for the year ended 30 June 2025.
The Company has made excellent strategic and financial progress during the
year, with total revenue rising by 33% and profit before tax increasing by
12%. The Company's two business segments-SAWsense and Translogik-have both
shown significant growth, supported by investments in engineering,
manufacturing, and product development.
SAWsense has transitioned from a licensing model to a full-service solution,
resulting in increased customer engagement and revenue conversion,
particularly in robotics, aerospace, motorsport, and electric propulsion
markets. A pilot production line and next-generation component development are
underway to support future scalability.
Translogik has undergone a transformation, expanding its customer base beyond
global tyre manufacturers to include direct sales in the road haulage and
transport sectors. This shift has been supported by new software partnerships,
subscription models, and improved in-house manufacturing capabilities. The
business unit has built a stronger pipeline and revamped its sales structure
to accelerate growth in FY26. New product variants and pricing strategies are
also expected to enhance competitiveness and market reach.
Royalty income from Bridgestone iTrack increased by 19% to £3.11m, although
future income will reduce due to a scheduled royalty rate cut. The Company
maintains a strong financial position with growing net assets and
distributable reserves, and continues to invest in growth.
Early trading in the new financial year shows promising momentum in both
SAWsense and Translogik, with healthy order books and customer pipelines
indicating a positive outlook for sustained strategic value and investor
returns.
Financial highlights:
• Total revenue up 33% to £5.55m (FY24: £4.18m)
• SAWsense revenue up 149% to £1.12m (FY24: 0.45m)
• Translogik revenue up 18% to £1.32m (FY24: £1.12m)
• Bridgestone iTrack royalty income up 19% to £3.11m (FY24:
£2.61m)
• Gross margin up to 89.9% of revenue (FY24: 87.6%)
• Profit before taxation up 12% to £1.41m (FY24:
£1.26m)
• Cash and cash equivalents at year end of £1.14m
(FY24: £1.28m)
• Distributable reserves at year end of £4.85m (FY24:
£3.44m)
Executive Chairman of Transense, Nigel Rogers, said:
"Excellent progress was made in executing our strategy during the year, and we
continue to deliver financial results in line with market expectation. Since
the sale of iTrack in June 2020 the Group has achieved consistent growth from
its operating businesses. SAWsense revenues have increased from £0.1m to
more than £1.1m in the year to 30 June 2025, and growth in Translogik in the
same period has moved from £0.5m to more than £1.3m.
During these five years the Group's strategy has focused on building the
revenue base of both SAWsense and Translogik to maintain profitability at
around the current level despite the expected reduction in Bridgestone
royalty income of around £1m in FY26.
The Board remains confident that this can be achieved. The visibility of
future revenues is improving continuously, although does not yet extend to a
full year ahead in granular detail. Accordingly, the directors maintain
close attention to short term forecasting to maintain flexibility during each
year.
Looking towards the medium to long term, the board are satisfied that the
conditions are in place to deliver significant strategic value and investor
returns, whilst managing cash headroom and investing in the people, products
and equipment that are necessary to capitalise on these exciting
opportunities."
Investor Presentation: 4pm, Tuesday 23 September 2025
Nigel Rogers (Executive Chairman), Ryan Maughan (Managing Director) and Melvyn
Segal (Chief Financial Officer) will provide a presentation to review the
Company's annual results and prospects at 4pm on Monday 23 September 2025. The
presentation will be hosted through the online platform Investor Meet Company.
To attend the presentation, investors can sign up to Investor Meet Company for
free and select to meet Transense Technologies plc via the following
link:https://www.investormeetcompany.com/transense-technologies-plc/register-investor
(https://www.investormeetcompany.com/transense-technologies-plc/register-investor)
. Investors who have already registered and selected to meet the Company will
automatically be invited to the presentation.
Questions can be submitted in real time during the presentation via the "Ask a
Question" function.
For further information please visit www.transense.com or contact:
Transense Technologies plc Via Investor Relations
Nigel Rogers (Executive Chairman) (see below)
Ryan Maughan (Managing Director)
Melvyn Segal (Chief Financial Officer)
Cavendish Capital Market Limited (Nominated Adviser and Broker) Tel: +44 (0)20 7 220 0500
Adrian Hadden / Callum Davidson (Corporate Finance)
Jasper Berry (Sales)
Investor Relations Tel: +44 (0)1869 238380 investor.relations@transense.co.uk
(mailto:investor.relations@transense.co.uk)
Anice McNamee
Notes to Editors:
Transense is headquartered in Oxfordshire, UK and its shares are traded on
AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company
develops and supplies advanced sensor technology and measurement solutions
used by some of the world's leading companies to improve performance,
efficiency, and safety in demanding, mission critical applications. Transense
currently operates through two active business segments:
· SAWsense - designs, supplies and licences advanced sensor
solutions based on proven, patent protected Surface Acoustic Wave (SAW)
technology to world leading companies in aerospace, automotive, and industrial
machinery (including robotics), enabling improved efficiency and performance
of their products. Key customers include GE Aerospace, Parker Meggitt, Motion
Applied (formerly McLaren Applied), Airbus and several other confidential Tier
One automotive, aerospace and industrial machinery suppliers.
· Translogik - develops smart, connected commercial vehicle tyre
inspection equipment to many of the world's leading tyre suppliers, fleet
operators and service centres. This enables accurate measurement and
digital capture of safety-critical tyre condition data, and is used to reduce
operating costs, improve safety and provide audit records for regulatory
compliance. Key customers include Bridgestone, Goodyear, Continental and
Prometeon (Pirelli), leading independent providers of vehicle fleet
maintenance management software, and a growing list of international territory
distribution partners.
In addition, Transense earns residual royalty income from Bridgestone iTrack -
a tyre monitoring system for off-highway vehicles that was developed by
Translogik. The associated sales, support and development infrastructure were
sold to Bridgestone Corporation, the world's largest tyre producer, in June
2020, and the intellectual property was licensed exclusively to Bridgestone
under a ten-year deal expiring in 2030.
Find out more at: https://www.transense.com/ (https://www.transense.com/)
CHAIRMAN'S STATEMENT
The Company has made excellent progress in the execution of strategy during
the year, whilst continuing to deliver financial results in line with market
expectation.
Business Strategy
The business strategy of the Company is to commercialise innovative sensing
and measurement solutions through its two active business segments: SAWsense
and Translogik.
SAWsense develops and supplies advanced sensor solutions for accurate,
non-contact measurement of torque, force, pressure, and temperature. Using
patent-protected Surface Acoustic Wave (SAW) sensor technology, SAWsense
serves blue-chip customers in Robotics, Aerospace, Electric Motors and Drives
(EMD), and Motorsport. The company has a skilled engineering team and is
investing in technology and manufacturing process development to support
customer demand and future growth.
Translogik, develops and supplies smart, connected tyre inspection equipment,
primarily for the truck and bus market. Translogik has historically sold tyre
inspection tools to major tyre manufacturers for their managed tyre
operations. The company now resells accompanying software and is investing in
new hardware products to expand its solutions to a growing global customer
base.
In addition, the Company earns residual royalty income from Bridgestone
iTrack, a system developed by the Company for monitoring mining haul tyre
performance which was licensed to Bridgestone Corporation for a ten-year
period expiring in 2030.
Financial Overview
Total revenue increased 33% to £5.55m and profit before tax was up 12% to
£1.41m.
Operating cash flow of £2.05m represented cash conversion of 145% of
operating profit, and this was matched by investment in plant, equipment and
development costs of £2.09m.
The financial position continued to strengthen with net assets increasing to
£7.12m or 47 pence per share (FY24: £5.57m and 37 pence respectively), and
available cash resources stood at £1.14m (FY24: £1.28m). The company holds
shares for treasury at total cost of £1.03m; an average cost of £0.84p per
share. Distributable reserves (net of treasury shares) closed at £4.85m
(FY24: £3.44m).
The directors are confident that the Company has the financial resources
necessary to continue to fund expected growth in the business, invest for the
future, and consider further returns to shareholders.
Business Overview
The financial year ending June 2025 witnessed substantial progress in the
development of both the SAWsense and Translogik business units, evidenced in
the growth in revenues, order book, and pipeline for these two business units.
SAWsense
SAWsense revenue more than doubled to reach £1.12m (FY24: £0.45m). The net
operating loss for the segment reduced by 35% to £0.46m (FY24: £0.71m), as
the business unit continues to make progress towards stand-alone
profitability.
The business model for SAWsense has been transformed in recent years. SAW
technology was originally presented by Transense to customers using a
licensing model, under which customers were free to develop application
engineering and source components in exchange for a licence fee and unit
royalty. Whilst this approach met with some initial success, the high level
of risk customers faced due to challenges with application engineering,
industrialisation, and supply chains was limiting the potential of the
business.
Under current management, SAWsense has addressed these issues by building an
engineering and production capability to offer customers a full-service
solution, substantially lowering their risk of adopting this "new"
technology. This has generated much higher levels of incoming enquiries and
vastly improved conversion to revenue.
Revenue is generated from production assemblies made at our facility at Weston
on the Green in low- to mid-volume, sale of approved components for authorised
customers to build into their own assemblies where higher volumes justify
their own production capabilities, non-recurring engineering (NRE) charges for
application engineering, prototyping and development of future products, as
well as securing government grant-support for collaborative development
activity with key customers.
Revenue for each of these categories increased as follows:
Type of revenue FY25 FY24
£m £m
Production assemblies 0.44 0.25
Componentry 0.07 -
NRE 0.21 0.14
Grant income 0.39 0.05
Royalty income 0.01 0.01
Total 1.12 0.45
SAWsense continues to focus on four market sectors in which there are
applications with clear differentiated benefits and strong customer pull:
Aerospace, Electric Motors & Drives (EMD), Industrial Machinery (including
Robotics) and Motorsport. There is demonstrable commercial traction in each
of these areas, with higher revenues, increased order books and more incoming
enquiries across all four.
Revenue was distributed as follows:
Market sector FY25 FY24
£m £m
Aerospace 0.39 0.12
Motorsport 0.44 0.26
EMD 0.27 0.06
Robotics 0.02 0.01
Total 1.12 0.45
SAWsense has quickly gained traction in the rapidly growing robotics market,
winning exciting development programmes with leading global technology
businesses and building a strong pipeline of new opportunities. These
programmes are expected to contribute significantly to revenue in the next
financial year and represent an opportunity for rapid growth in the near-term
if our customers' new products are launched as planned, and are successful in
the market.
The Company continues to work with Motion Applied (MA), formerly known as
McLaren Applied, in the motorsport market. MA is an excellent partner with a
global presence and is the market leader for control electronics and telemetry
software solutions working with almost every major racing team and
championship in the world. This partnership has delivered significant
revenue growth in FY25 and should be a major driver of growth in the new
financial year if opportunities in the pipeline meet expectations.
The Company has made progress in the Electric Motors and Drives (EMD) market,
working with leading global tier 1 suppliers of electric propulsion systems
for the automotive and eBike markets. Work continues on existing projects and
develop new opportunities in this sector. Revenues from engineering will
continue to grow in the near-term and there is a significant opportunity for
mid-term progress into production.
SAWsense is firmly established in the aerospace market, and the Company is
engaged in programmes with leading aerospace businesses. During the year,
the Company has become more deeply engaged as a key supplier to GE Aerospace
for the T901 and other engine programmes. The sector represents a robust
longer-term opportunity, and will contribute significantly to revenue in the
new financial year, both from engineering development and component sales.
Continued investment has been committed in the development of key SAW
components and manufacturing processes to support future customer programmes
continues, adding substantial long-term value to the business.
With sales momentum gathering pace, a pilot production line is being installed
at the Weston on the Green facility. This line will allow the Company to
demonstrate semi-automated, high-volume capable manufacturing processes for
the preparation of incoming machined parts, placement of sensing elements,
installation of RF couplers and automated calibration of finished
assemblies. The pilot line will help to de-risk adoption by higher volume
customers and also provide capacity to significantly improve processes that
have historically been performed manually for niche low volume manufacture. It
is envisaged that some customers will seek to bring similar capabilities
in-house to their own facilities, or those of Tier 1 suppliers, and purchase
approved components from SAWsense to fulfil their demand.
In addition to commissioning the pilot line, there are also programmes
underway to design and develop a suite of next-generation components including
innovative sensing elements and a new Application Specific Integrated Circuit
(ASIC). These investment programmes commenced late in FY24, progressed
through FY25 and are due for completion during FY26.
Revenue visibility is gaining strong momentum, with FY25 order intake already
outpacing revenues. The year-end order book reached £0.24m (FY24: £0.12m),
excluding grant income. With a growing pipeline of larger, higher-quality
opportunities, management is investing in SAWsense at record levels to scale
rapidly and unlock an exciting growth trajectory.
Translogik
Our range of tyre inspection equipment marketed under the Translogik brand
generated revenue of £1.32m; an increase of 18% over the prior year (FY24:
£1.12m). Gross margin improved by 8% to 62% (FY24: 54%) as a result of
bringing assembly of the product range in-house in the early part of the
financial year. The segmental overhead increased from £0.22m to £0.45m,
reflecting the recruitment of people in operations and product development.
The segmental operating profit for the year was almost unchanged at £0.37m,
although the cost base now in place is sufficient to support much higher
activity levels as new products are launched and customers are converted.
Historically, the market for Translogik products was with global tyre
manufacturers who use the tools in their commercial vehicle businesses to
enable rapid and accurate tyre inspection data to be captured. This data is
analysed using the customer's own software systems to help manage large fleet
tyre usage and deliver traceable records for legislative compliance.
Significant opportunities to grow more direct business in the road haulage and
transport sector are now underway, by providing tyre inspection tools and data
management software to a wider section of the market. This includes
partnering with software providers, both as resellers of our hardware and as
providers of software to bundle and offer our customers on subscription. It
also includes appointing stockholding distributors in key overseas territories
to expand geographical reach.
Translogik has undergone transformative change this year. New in-house
manufacturing has delivered enhanced throughput, quality, and margins.
Significant growth in sales to new customers and through new routes to market
reduced dependence on a small group of global tyre manufacturer customers.
Revenue opportunities have been created through software partnerships and
subscription sales.
The transformation proved timely and would have resulted in stronger revenue
growth were it not for a temporary pause in demand from one global tyre major
unconnected with our products. Growth in the business, adjusted to reflect
the contribution from this customer, would have been over 50% compared with
the prior year.
Revenue by customer type was as follows:
Type of customer FY25 FY24
£m £m
Global tyre majors 0.65 0.63
Fleets/service providers 0.06 0.02
Software resellers 0.41 0.23
Distribution resellers 0.09 0.06
Others (minor) 0.11 0.18
Total 1.32 1.12
Towards the end of the financial year the sales structure of Translogik was
revamped, in order to refocus on the conversion of strategic customer
relationships and development of a longer term pipeline with better
visibility. The effects are already evident and are expected to accelerate
growth in FY26.
This activity is supported by product initiatives, including more competitive
pricing of premium models achieved by passing through savings achieved by
in-house assembly and better sourcing of components. There are also new
variants and complementary products close to launch in coming months. The
business unit is now well-positioned for future growth, adding new customers,
routes to market, and investing in new product development.
iTrack Royalty Income
Royalty income from Bridgestone iTrack generated income of £3.11m during the
year, representing an increase of 19% over the prior year (FY23: £2.61m). The
underlying volume increase was somewhat greater at 24% but was diluted by a
weakening of the US dollar conversion rate in the second half of the financial
year. Over the five completed years since the inception of the licence, it has
generated more than £10m in royalty income. New installations in the year
ran at the highest rate since inception of the iTrack deal and the closing
annualised royalty rate was US$4.03m. This financial year represented the
final year at the full royalty rate, which will reduce by 40% in the current
financial year in accordance with the licence agreement.
Current Trading and Outlook
Revenues for SAWsense and Translogik combined for the first two months of the
current financial year to 30 June 2026 (FY26) are 23% up on the equivalent
period last year. The royalty income from Bridgestone iTrack for the same
period has reduced by approximately 30% reflecting the reduction in the unit
rate effective from the start of July 2025 offset by the volume increase.
The SAWsense open order book currently stands at £0.47m (excluding grant
income) having started FY26 at £0.24m. Translogik revenues, which have
historically been transactional with minimal forward order book, will now
benefit from a significant contracted subscription deal which will impact in
FY26, and an expanding pipeline of new customer opportunities.
Since the sale of iTrack in June 2020 the Group has achieved consistent growth
from its operating businesses. SAWsense revenues have increased from less
than £0.1m to more than £1.1m in the year to 30 June 2025, and growth in
Translogik in the same period has moved from £0.5m to more than £1.3m.
During these five years the Group's strategy has focused on building the
revenue base of both SAWsense and Translogik to maintain profitability at
around the current level despite the expected reduction in royalty income of
around £1m in FY26.
The Board remain confident that this can be achieved. The visibility of
future revenues is improving continuously, although does not yet extend to a
full year ahead in granular detail. Accordingly, the directors maintain
close attention to short-term forecasting to maintain flexibility during each
year.
Looking towards the medium to long term, the Board are satisfied that the
conditions are in place to deliver significant strategic value and investor
returns, whilst managing cash headroom and investing in the people, products
and equipment that are necessary to capitalise on these exciting
opportunities.
Consolidated Statement of Comprehensive Income
For the year ended 30 June 2025
Year ended Year ended
30 June 30 June
2025 2024
£'000 £'000
Revenue 5,162 4,180
Grant Income 388 -
Total Revenue 5,550 4,180
Cost of sales (556) (526)
---------------------------------------------- ----------------------------------------------
Gross profit 4,994 3,654
Administrative expenses (3,586) (2,373)
Exceptional administrative expenses - (47)
---------------------------------------------- ----------------------------------------------
Operating Profit 1,408 1,234
Financial income/(expense) - 26
Other income - 5
---------------------------------------------- ----------------------------------------------
Profit before taxation 1,408 1,265
Taxation - 300
---------------------------------------------- ----------------------------------------------
Profit and total comprehensive income for the year attributable 1,408 1,565
To the equity holders of the parent ---------------------------------------------- ----------------------------------------------
Basic profit per share for the year (pence) 9.25 10.13
========================================== ==========================================
Consolidated Balance Sheet
At 30 June 2025
At 30 June At 30 June
2025 2025 2024 2024
£'000 £'000 £'000 £'000
Non current assets
Property, plant and equipment 1,551 889
Intangible assets 2,118 1,034
Deferred tax 1,475 1,475
---------------------------------------------- ----------------------------------------------
5,144 3,398
Current assets
Inventories 377 390
Trade and other receivables 1,637 1,395
Cash and cash equivalents 1,138 1,281
---------------------------------------------- ----------------------------------------------
3,152 3,066
---------------------------------------------- ----------------------------------------------
Total assets 8,296 6,464
Current liabilities
Trade and other payables (808) (493)
Lease liabilities (115) (100)
---------------------------------------------- ----------------------------------------------
(923) (593)
Non current liabilities
Lease liabilities (252) (304)
---------------------------------------------- --------------------------------------
Total liabilities (1,175) (897)
---------------------------------------------- --------------------------------------
Net assets 7,121 5,567
========================================== ==================================
Equity
Issued share capital 1,644 1,644
Share premium 65 65
Treasury Shares (1,027) (1,027)
Share based payments 564 418
Retained earnings/(accumulated loss) 5,875 4,467
---------------------------------------------- ----------------------------------------------
Total equity 7,121 5,567
============================================== ==============================================
Consolidated Statement of Changes in Equity
For the year ended 30 June 2025
Share Share Share based payments Retained earnings Treasury Shares Total
capital premium Equity
£'000 £'000 £'000 £'000 £'000
Balance at 1 July 2023 1,644 65 288 2,902 (708) 4,191
Comprehensive income for the year:
Profit for the year - - - 1,565 - 1,565
Share based payment - - 130 - - 130
Treasury shares - - - - (319) (319)
------------------------------ ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ----------------------------------------------
Balance at 30 June 2024 1,644 65 418 4,467 (1,027) 5,567
------------------------------ ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ----------------------------------------------
Share Share Share based payments Retained earnings Treasury Shares Total
capital premium Equity
£'000 £'000 £'000 £'000 £'000 £'000
Balance at 1 July 2024 1,644 65 418 2,902 (708) 4,191
Comprehensive income for the year:
Profit for the year - - - 1,408 - 1,408
Share based payment - - 146 - - 146
Treasury shares - - - - - -
------------------------------ ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ----------------------------------------------
Balance at 30 June 2025 1,644 65 564 5,875 (1,027) 7,121
------------------------------ ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ----------------------------------------------
Consolidated Cash Flow Statement
For the year ended 30 June 2025
Year ended 30 June Year ended 30 June
2025 2024
£'000 £'000
Profit/(loss) from operations 1,408 1,565
Adjustments for:
Taxation - (300)
Net financial income - (26)
Share based payment 146 130
Depreciation 239 145
Profit on sale of property, plant and equipment (2) -
Amortisation and impairment of intangible assets 172 152
---------------------------------------------- ----------------------------------------------
Operating cash flows before movements in working capital 1,963 1,666
(Increase) in receivables (242) (132)
Increase in payables 315 159
Decrease/(increase) in inventories 13 (130)
---------------------------------------------- ----------------------------------------------
Net cash generated in operations 2,049 1,563
---------------------------------------------- ----------------------------------------------
Investing activities
Acquisitions of property, plant and equipment (839) (428)
Acquisitions of intangible assets (1,256) (455)
Proceeds from sale of property, plant and equipment 2 -
---------------------------------------------- ----------------------------------------------
Net cash (used in)/generated from investing activities (2,093) (883)
---------------------------------------------- ----------------------------------------------
Financing activities
Treasury shares - (319)
Interest received/(paid) - 26
Payment of lease liabilities (99) (84)
---------------------------------------------- ----------------------------------------------
Net cash used in financing activities (99) (377)
---------------------------------------------- ----------------------------------------------
Net increase/(decrease) in cash and cash equivalents (143) 303
Cash and equivalents at the beginning of year 1,281 978
---------------------------------------------- ----------------------------------------------
Cash and equivalents at the end of year 1,138 1,281
============================================== ==============================================
NOTES RELATING TO THE COMPANY FINANCIAL STATEMENTS
BASIS OF PREPARATION
The consolidated statement of comprehensive income, the consolidated balance
sheet, the consolidated statement of changes in equity, the consolidated cash
flow statement and the associated notes for the year ended 30 June 2025 have
been extracted from the Group's financial statements upon which the auditor's
opinion is unqualified and does not include any statement under section 498 of
the Companies Act 2006.
Whilst the financial information included in this preliminary announcement has
been computed in accordance with UK adopted international accounting
standards, this announcement does not itself contain sufficient information to
comply with all IFRS disclosure requirements. The Company's 2024 Annual Report
and Accounts will be prepared in compliance with UK-adopted International
Accounting Standards (IFRS).
1 SEGMENT INFORMATION
The Company had three reportable segments being the unique trading divisions,
SAWsense and Translogik, which make use of technology developed by the Company
to measure and record temperature, pressure and torque, and the iTrack royalty
activity in respect of income from licensed technology.
Revenue and EBITDA are the Company's key focus and in turn is the main
performance measure adopted by management.
The tables below set out the Company's revenue split and operating segments.
These disclose information for continuing operations and in view of their
relative size, information for discontinued operations. The disposal of iTrack
operations will result in future royalty income replacing direct sales income
and costs.
Revenue
Year ended Year ended
30 June 2025 30 June 2024
£'000 £'000
North America 347 464
South America 133 121
Australia 18 4
Europe 660 514
UK 489 323
Rest of the World 401 144
-------------------------------------------- --------------------------------------------
2,048 1,570
======================================= =======================================
iTrack
Royalty
3,114 2,610
Grant
Income
388 -
Total
Revenue
5,550 4,180
Segments
Translogik SAW iTrack royalties Unallocated Total
£'000 £'000 £'000 £'000 £'000
Year ended 30 June 2025
Sales 1,322 728 3,114 - 5,162
Grant income - 388 - - -
----------------------------- ----------------------------- ----------------------------- ----------------------------- -----------------------------
1,322 1,114 3,114 - 5,550
================ ================ ================ =============== ================
Gross profit 819 1,061 3,114 - 4,994
Administrative expenses (451) (1,518) (44) (1,573) (3,586)
----------------------------- ----------------------------- ----------------------------- ----------------------------- -----------------------------
Operating profit/(loss) 368 (457) 3,070 (1,573) 1,408
Net financial income - - - - -
Taxation - - - - -
----------------------------- ---------------------------- ----------------------------- ----------------------------- -----------------------------
Profit/(loss) for the year 368 (457) 3,070 (1,573) 1,408
========== ========== ========== ========== ==========
EBITDA reconciliation
Operating profit 1,408
Depreciation and amortisation 409
------------------
EBITDA 1,817
==========
Adjusted EBITDA (excluding share based payments and exceptional administrative 1,963
expense)
==========
Translogik SAW iTrack royalties Unallocated Total
£'000 £'000 £'000 £'000 £'000
Year ended 30 June 2024
Sales 1,120 450 2,610 - 4,180
================== =================== =================== ================= ====================
Gross profit 604 440 2,610 - 3,654
Administrative expenses (221) (1,159) (44) (949) (2,373)
Exceptional administrative expenses (42) - (5) (47)
-------------------------- -------------------------- -------------------------- -------------------------- -----------------------------
Operating profit/(loss) 341 (719) 2,566 (954) 1,234
Other income - 5 - - 5
Net financial income - - - 26 26
Taxation - - - 300 300
-------------------------- -------------------------- -------------------------- -------------------------- ---------------------
Profit/(loss) for the year 341 (714) 2,566 (628) 1,565
During the year ended 30 June 2025 there was 1 customer (2024: 1) whose
turnover accounted for more than 10% of the Company's total continuing revenue
as follows:
Year ended 30 June 2025 Revenue Percentage of total
£'000
Customer A 3,114 56
Year ended 30 June 2024 Revenue Percentage of total
£000
Customer A 2,610 62
2 TAXATION
Recognised in the statement of comprehensive income in respect of continuing
operations
Year ended Year ended
30 June 2025 30 June 2024
£'000 £'000
Deferred tax credit
Current year - (300)
--------------------------------------------- ---------------------------------------------
Tax credit in Statement of Comprehensive Income - (300)
============================================ ============================================
Reconciliation of effective tax rate
Year ended Year ended 30 June 2024
30 June 2025
£'000 £'000
Profit before tax 1,265 1,265
============================================= =============================================
Tax calculated at the average standard UK corporation tax rate of 25.00% 352 316
(2024: 25.00%)
Expenses not deductible for tax purposes 36 33
Utilisation of losses brought forward for which no deferred tax asset was (388) (24)
recognised
Recognition of deferred tax in respect of prior year losses - (625)
---------------------------------------------- ----------------------------------------------
Total tax credit - (300)
============================================= =============================================
Deferred tax assets are
Recognised - in respect of tax losses 1,475 1,475
Unrecognised - in respect of tax losses and other timing differences 3,358 3,706
============================================= =============================================
The applicable UK corporation tax rate is 25% (2024: 25%). The Group has tax
losses, subject to agreement by HM Revenue and Customs, in the sum of £19.3m
(2024: £20.7m), which are available for offset against future profits of the
same trade. There is no expiry date for tax losses. An appropriate deferred
tax asset is being recognised as the Group is able to demonstrate a reasonable
expectation of sufficient future taxable profits arising in order to utilise
the losses.
3 EARNINGS PER SHARE
Year ended 30 June 2025 Year ended 30 June 2024
Number Number
-------------------- -------------------
Weighted average number of shares - basic 15,219,884 15,446,993
============ ===========
Basic profit per share is calculated by dividing the profit by the weighted
average number of ordinary shares in issue during the year of 15,219,884
(2024: 15,446,993). This excludes treasury shares held by the Company.
Year ended 30 June 2025 Year ended 30 June 2024
£'000 £'000
Profit/(loss) 1,408 1,565
-------------------- --------------------
Basic profit per share (pence) 9.25 10.13
Fully diluted profit per share (pence) 9.03 9.89
There are 1,532,500 share options and no warrants in place at 30 June 2025
(1,532,500 share options at 30 June 2024).
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FR UUUKRVOUKUARRecent news on Transense Technologies
See all newsREG - Transense Technlgy - Final Results
AnnouncementREG - Transense Technlgy - Notice of Results
AnnouncementRCS - Transense Technlgy - Products update
AnnouncementREG - Transense Technlgy - TR-1
AnnouncementREG - Transense Technlgy - Director/PDMR Shareholding - acquisition of shares
Announcement